Human bone marrow mesenchimal stem cells growth rate dynamics, immunophenotype and genetic stability on early and late passages at ex vivo culturing
https://doi.org/10.17650/1818-8346-2009-0-1-44-50
Abstract
Human mesenchimal stem cells (MSC) growth dynamics, immunophenotype change, genetic stability on early (3—4) and late (10—12) passages at in vitro culturing was studied. Results of bone marrow stromal fibroblasts culturing (n=25) from allogeneic transplant recipients with hematological disorders are presented. It has been shown, that in MSC population cultivated in vitro linear homogeneity of cells is observed on 3—4 passage, and remains on 10—12 passage. Clonal heterogeneities of MSC population and selective advantage of certain clones during culturing was revealed as aneuploidy analysis results of cultivated cells. The MSC culturing protocol used in our work allows receiving well characterized MSC number sufficient for clinical application as early as 3—4 passage. While using in the therapeutic purposes MSC later terms of expansion it is necessary to have close control of cells immunophenotype and genetic stability, which will allow avoiding in the future the undesirable long-term consequences of MSC cultures clinical use. The obtained data are discussed and compared with literature data.
About the Authors
E. Yu. OsipovaRussian Federation
Moscow
V. A. Nikitina
Russian Federation
Moscow
T. A. Astrelina
Russian Federation
Moscow
A. Yu. Ustyugov
Russian Federation
Moscow
E. V. Dmitrieva
Russian Federation
Moscow
B. B. Purbueva
Russian Federation
Moscow
E. V. Skorobogatova
Russian Federation
Moscow
T. V. Schamanckaya
Russian Federation
Moscow
Z. M. Dischlevaya
Russian Federation
Moscow
M. V. Yakovleva
Russian Federation
Moscow
O. A. Maiorova
Russian Federation
Moscow
L. D. Katosova
Russian Federation
Moscow
S. A. Roumiantsev
Russian Federation
Moscow
N. P. Bochkov
Russian Federation
Moscow
References
1. Фриденштейн А.Я., Чайлахян Р.К., Лалыкина К.С. О фибробластоподобных клетках в культурах кроветворных тканей морских свинок. Цитология 1970;12:1147—55.
2. Фриденштейн А.Я., Лурия Е.А. Клеточные основы кроветворного микроокружения. Тер арх 1980;9:67—71.
3. Владимирская Е.Б., Кошель И.В. Стромальные фибробласты нормального костного мозга у детей. Гематол трансфузиол 1990;1:3—5.
4. Фриденштейн А.Я., Чайлахян Р.К. Стромальные клетки костного мозга и кроветворное микроокружение. Арх патол 1982;10:3—11.
5. Owen M., Fridenstain A. Stromal stem cells: marrow-derived osteogenic progenitors. Ciba Found Symp 1988;136:42—60.
6. Owen M. Marrow stromal stem cells. J Cell Sci 1995;10:63—76.
7. Minguell J.J. Mesenchymal stem cells. Exp Biol Med 2001;226(6):507—20.
8. Minguell J.J., Conget P. Mesenchymal progenitor cell: Biology and clinical utilization. Br J Med Biol Res 2000;33: 881—7.
9. Prockop D.J. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997;276:71—4.
10. Castro-Malaspina H., Gay R., Resnick G. et al. Characterization of human bone marrow fibroblast colonyforming cells (CFU-F) and their progeny. Blood 1980;56:289—301.
11. Caplan A.I. The mesengenik process. Clin Plast Surg 1994;21:429—35.
12. Pittenger M., Mackay A., Beck S. et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143—7.
13. Le Blanc K., Ringden O. Immunomodulation by mesenchymal stem cells and clinical experience. J Intern Med 2007;262:509—25.
14. Miura M., Miura Y., Hesed M. et al. Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells to malignant transformation. Stem Cells 2005;65:1961—4.
15. Stenderup K., Justesen J., Clausen C. et al. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 2003;33:919—26.
16. Tai M.-H., Chang C.-C., Olson L.K. et al. Oct4 expression in adult human stem cells: evidence in support of the stem cell theory of carcinogenesis. Carcinogenesis 2004;10:1093.
17. Rubio D., Garcia-Castro L., Martin M.C. et al. Spontaneous human adult stem cell transformation. Cancer Res 2005;65:3035—9.
18. Kassem M., Burn J.S. Carcia-Castro J. et al. Adult stem cells and cancer. Cancer Res 2005;65:9601—7.
19. Фриденштейн А.Я., Дериглазова Ю.Ф., Кулагина Н.Н. Клонирование клеток-предшественников для фибробластов в монослойных культурах клеток. Бюлл экспер биол 1973;76:90—4.
20. Shaffer L.G., Tommerup N. International System for Human Cytogenetic Nomenclature. Published in collaboration with Сytogenetics and Genome Research under the title ISCN. Karger 2005:130.
21. Delorme B., Ringe J., Gallay N. et al. Specific plasma membrane protein phenotype of culture-amplified and native human bone marrow mesenchymal stem cells. Blood 2008;111:2631—5.
22. Назаренко С.А., Тимошевский В.А. Анализ частоты спонтанной анеуплоидии в соматических клетках человека с помощью технологии интерфазной цитогенетики. Генетика 2004;40(2):195—204.
23. Бочков Н.П., Никитина В.А. Цитогенетика стволовых клеток человека. Молекуляр мед 2008;3:40—7.
Review
For citations:
Osipova E.Yu., Nikitina V.A., Astrelina T.A., Ustyugov A.Yu., Dmitrieva E.V., Purbueva B.B., Skorobogatova E.V., Schamanckaya T.V., Dischlevaya Z.M., Yakovleva M.V., Maiorova O.A., Katosova L.D., Roumiantsev S.A., Bochkov N.P. Human bone marrow mesenchimal stem cells growth rate dynamics, immunophenotype and genetic stability on early and late passages at ex vivo culturing. Oncohematology. 2009;(1):44-50. (In Russ.) https://doi.org/10.17650/1818-8346-2009-0-1-44-50